We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaborat... Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. Show more
REDWOOD CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
- Preliminary LUNA data presented at the Annual Meeting of the Macula Society support potential best-in-class clinical activity and an encouraging safety profile in patients with wet AMD...
REDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.84 | -16.182937555 | 11.37 | 11.87 | 8.76 | 503246 | 9.78074624 | CS |
4 | -4.61 | -32.6025459689 | 14.14 | 14.21 | 8.76 | 267697 | 11.10996634 | CS |
12 | -7.57 | -44.269005848 | 17.1 | 29.8 | 8.76 | 2072560 | 19.45144501 | CS |
26 | 0.227 | 2.4400730947 | 9.303 | 29.8 | 7.4 | 1223802 | 17.36627795 | CS |
52 | 1.926 | 25.3287743293 | 7.604 | 29.8 | 7.21 | 794180 | 17.02539888 | CS |
156 | -33.87 | -78.0414746544 | 43.4 | 44.6 | 5.31 | 1206395 | 21.19248556 | CS |
260 | -57.97 | -85.8814814815 | 67.5 | 269.8 | 5.31 | 1207276 | 61.34161005 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions